Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Minority Interest (2022 - 2023)

Historic Minority Interest for Zentalis Pharmaceuticals (ZNTL) over the last 2 years, with Q4 2023 value amounting to $107000.0.

  • Zentalis Pharmaceuticals' Minority Interest fell 5158.37% to $107000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $107000.0, marking a year-over-year decrease of 5158.37%. This contributed to the annual value of $107000.0 for FY2023, which is 5158.37% down from last year.
  • According to the latest figures from Q4 2023, Zentalis Pharmaceuticals' Minority Interest is $107000.0, which was down 5158.37% from $129000.0 recorded in Q3 2023.
  • In the past 5 years, Zentalis Pharmaceuticals' Minority Interest registered a high of $368000.0 during Q1 2022, and its lowest value of $107000.0 during Q4 2023.